This trial is testing whether a different immunosuppressant drug may improve cognitive function in renal transplant patients.
2 Primary · 6 Secondary · Reporting Duration: Baseline to month 4
Experimental Treatment
60 Total Participants · 1 Treatment Group
Primary Treatment: Change from Prograf to Envarsus XR · No Placebo Group · Phase 4
Age 18 - 70 · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: